The efficacy of antimetabolic therapy of malignant neoplasms could not be explained solely by the direct mechanisms of action of such energy metabolism inhibitors as sodium dichloroacetate (DCA) and metformin (MTF). The indirect effects of DCA and MTF on the organs and tissues, which could play significant role in the antitumor activity of these agents, have not been tho roughly explored. Aim: To investigate the effect of MTF, DCA and their combination on the survival of rats with C6 glioma and major haematological and biochemical blood parameters. Materials and Methods: DCA and MTF were administered orally to inbred female rats for 11 days starting from the second day after tumor cell transplantation at a total dose of 1.1 and 2.6 g/kg, respectively. When combined treatment was used, MTF was administered 3 hours after the administration of DCA. The content of lactate and pyruvate in blood plasma was determined on the ChemWell ® 2910 (Combi) automatic analyzer. Blood parameters were determined using the Particle Counter PCE210 automatic hematology analyzer. Results: The administration of DCA did not significantly affect the life span of rats with C6 glioma. Duration of life of rats, which were administered with MTF only, was significantly higher (by 19.1%, p < 0.01). Combined administration of DCA + MTF prolonged life span of animals with glioma by 50% (p < 0.001). The positive result of antitumor activity of MTF alone and in combination with DCA correlated with a decrease in the mean platelet volume/platelet count (MPV/PLT) ratio by 75.0% (p < 0.05) compared with tumor control. In addition, the expressed antitumor effect of combination therapy with DCA and MTF was associated with a decrease (p < 0.05) in glucose and lactate levels in blood plasma of rats with C6 glioma by 10% and 41.4%, respectively, compared to tumor control. Analysis of blood parameters showed that the growth of C6 glioma was accompanied by the development of leukopenia, anemia and thrombocytopenia. The introduction of DCA caused the correction of manifestations of anemia and leukopenia, but did not affect the level of platelets in the blood of animals with glioma. MTF alone and in combination with DCA positively influenced the number of white blood cells and caused complete thrombocytopenia correction, increasing platelet count by more than 200% (p < 0.001). Conclusion: The ability of MTF either used alone or in combination with DCA to influence the development of C6 glioma which is manifested in an increase in the lifespan of rats has been revealed. The most pronounced antitumor effect was recorded against the background of the combined use of these agents, which may be due to their ability to lower the levels of lactate and glucose in the blood of tumorbearing rats. It is proved that MTF both in monotherapy and in combination with DCA provides correction of anemia and thrombocytopenia, which arise at the background of glioma C6 growth.
In the last decade significant progress has �een achieved in understanding the mechanisms of repro gramming the energy meta�olism of malignant cells� and as a result� the efforts of many researchers are now aimed at developing a new direction of antitumor therapy -antimeta�olic therapy. Therefore� due to high antitumor activity� such inhi�itors of energy meta�olism as sodium dichloroacetate �DCA� and metformin �MTF� have �een widely studied �y oncologists. Both agents have long �een used extensively in clinical practice for the treatment of pathologies not related to cancer. For example� the safety and efficacy of DCA has �een pro ven in the case of the correction of lactic acidosis� where DCA therapy effectively reduces the level of lactate in the �lood �y stimulating the pyruvate oxidation [�] . MTF is a hypoglycemic drug that is used as the first line of therapy for hyperglycemia and insulin resistance for more than �� years. Recent studies have shown that the a�ility of MTF to lower �lood glucose levels is due to numerous mechanisms� including the activation of �'AMPactivated protein kinase� reduction of cyclic AMP production� inhi�ition of �st complex of the elec tron transport chain of mitochondria� and others [�] .
The features of the energy meta�olism of malignant cells associated with the intensification of glycolysis and the decrease in ATP production due to mitochon drial oxidation have attracted attention of scientists to the possi�ilities of using DCA and MTF in oncology as potentially simple and effective pharmacological agents for treatment of glycolytic malignant tumors. Numerous studies of these agents have shown their a�ility to exhi�it antitumor properties in many experi mental tumor and cell models [3�9] . However� high meta�olic plasticity of malignant cells caused sig nificant fluctuations in the effectiveness of antitumor action of these drugs administered in a monotherapy regimen. The most effective approach was the com Submitted: September 05, 2018. *Correspondence: E-mail: oncom@online.ua Abbreviations used: DCA -sodium dichloroacetate; GR -granulocytes; HCT -hematocrit; Hgb -hemoglobin; LY -lymphocytes; MCH -mean cell hemoglobin; MCHC -mean corpuscular hemoglobin concentration; MCV -mean cell volume; MO -monocytes; MPV -mean platelet volume; MTF -metformin; PCT -plateletcrit; PDW -platelet distribution width; PLT -platelet; RBC -red blood cells; WBC -white blood cells.
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It should �e noted that the analysis of the results of experimental studies suggests that the antitumor efficacy of DCA and MTF in in vivo experiments is sig nificantly higher than their cytotoxic/cytostatic effects on malignant cells in vitro. This is due to the fact that the reprogramming of the energy meta�olism of malignant cells significantly depends on their microenvironment� which is characterized �y a meta�olic deficiency of the main energy su�strates due to inadequate vasculariza tion of malignant tumors [�3] . The presence or a�sence of humoral factors and nutrient su�strates in tumor cells microenvironment may also affect the response of these cells to DCA and MTFinduced reprogramming of en ergy meta�olism. Moreover� DCA and MTF may cause a decrease in the level of such circulating su�strates important for tumor cell survival as glucose and lactate� not due to direct action on tumor cells� �ut indirectly through the influence on normal organs and systems of the �ody. Unfortunately� the study of the influence of these agents on the hematological parameters of animals with tumors and the possi�le relation with their antitumor activity were practically not carried out.
That is why the aim of this work was to study the effect of MTF� DCA and their com�ination on the survival of rats with C6 glioma and �asic animal �lood parameters.
MATERIALS AND METHODS
The studies were carried out on in�red female rats �.��3 months old weighing ����3� g from the vivarium of the R.E. Kavetsky Institute of Experimental Pathology� Oncology and Radio�iology �IEPOR� of the National Academy of �ciences of Ukraine �NA�U�� Kyiv� Ukraine. The research on animals was carried out in accordance with the provisions of the General Ethical Principles of Animal Experiments adopted �y the First Congress on Bioethics �Kyiv� ����� and international requirements in accordance with the European Convention for the Protection of Verte�rate Animals Used for Experimental and Other Purposes ��tras�ourg� �9�6�.
As an experimental tumor model� glioma C6 cell line was used� which was o�tained from the National Bank of Cell Lines and Tumor �trains of IEPOR NA�U. C6 glio ma cells were cultured in vitro in DMEM with ��% fetal calf se rum ��igma� U�A�� � mM Lglutamine and �� mg/ml gen tamicin at 37 °С in humidified atmosphere with �% СО � .
Transfusion of glioma C6 cells was carried out under general anesthesia �y intracere�ral inoculation of 0.6 • 10 6 cells in �.�� ml of physiological saline in the left parietal zone.
After transplantation� the rats were randomized �y weight and distri�uted into � groups: rats� which were administered only DCA in a total dose of �.� g/kg �n = ���; rats� which were administered with MTF only in a total dose of �.6 g/kg �n = ���; rats administered with �oth MTF and DCA �n = �3�; rats� which were adminis tered with water only �control� n = ���. As intact controls� healthy animals were used� the age� gender and weight of which fully corresponded to the experimental rats at the start of the research. In com�ination therapy� the aqueous solution of MTF was administered 3 h af ter administration of DCA in the total doses of �.6 and �.� g/kg� respectively. The doses of all pharmacologic agents studied corresponded to the range of therapeu tic doses for rats and were lower than the maximum tolerated dose [��] .
The agents were dissolved in water and adminis tered orally via pro�e n a volume of � ml/animal� once daily� starting from the second day after inoculation of tumor cells. In total �� administratons were made.
In order to assess the antitumor effect of the agents under study with respect to the C6 glioma� the aver age life span of animals in each experimental group was assessed.
Research of the main �lood indices of rats with C6 glioma after treatment with DCA� MTF and their com �ination was carried out at the �3 th day after inoculation of tumor cells. To determine the content of lactate and glucose� peripheral �lood was collected in heparin ized tu�es� followed �y centrifugation at 3��� rpm� and stored at ��� °C until further investigation on a full automatic ChemWell ® �9�� �Com�i� analyzer. Determi nation of hemoglo�in �Hg�� concentration� hematocrit �HCT� values� erythrocyte� leukocytes� and platelets �PLT� counts� and the calculation of erythrocytic and PLT indices in the whole �lood of rats collected in EDTA tu�es� was performed using an automatic hematology analyzer Particle Counter PCE���.
�tatistical analysis of the data was performed using descriptive methods� correlation analysis� nonlinear re gression analysis� �tudents tcriterion� Mann -Whitney Ucriterion using Microsoft Excel� �tatistic and Micro cal Origin software. The data are presented as M ± m� where M is the mean value� m is the standard deviation.
RESULTS AND DISCUSSION
The results of the study showed that� after inocu lation of glioma C6 cells in� a �rain tumor developed in ���% of rats� which �in the a�sence of therapy� caused the death of all animals on average in ��� �6 days. Analysis of �lood parameters showed that growth of C6 glioma was accompanied �y the deve lopment of leukopenia� anemia and throm�ocytopenia� whose manifestations can affect the life expectancy of rats. Thus� on the �3 th day after transplantation of tumor cells in the �lood of rats� there was registered more than twofold �p < �.��� reduction of the total leukocytes �white �lood cells -WBC� counts and� respectively� counts of lymphocytes �LY�� monocytes �MO� and granulocytes �GR� compared to the corre sponding indices in intact animals �Ta�le ��. Experimental Oncology ��� �������� ���� ��eptem�er� ��� �������� ���� ��eptem�er� ��eptem�er� ��7
The development of anemia in rats with C6 glioma was confirmed �y a significant �p < �.��� decrease in the num�er of red �lood cells �RBC� �y ��.�%� Hg� levels �y 9�6% and HCT �y ��6% compared with those for healthy animals. At the same time� the type of anemia had the character of macrocytic� since mean cell volume �MCV�� an index of an average volume of erythrocytes� was significantly higher in the �lood of tumor�earing rats than in intact controls ��y 7.�%� p < �����.
However� this did not affect the RBC indices associ ated with MCV� i.e. mean cell hemoglo�in �MCH; the Hg� content per erythrocyte� and mean corpuscular hemoglo�in concentration �MCHC; the Hg� content per volume unit of one erythrocyte�� since they were within the normal range �Ta�le ��.
In addition to the registered leukopenia and ane mia� the growth of C6 glioma was characterized �y the development of severe throm�ocytopenia� as shown �y a significant decrease �p < �.��� in the counts of PLT �y 6��7% and plateletcrit �PCT� �y ����% �Ta�le �� as a result of excessive destruction of these cells [��] . Moreover� there is a highly heterogeneous PLT popula tion in the �lood of rats with a tumor� indicated �y a sig nificant increase in their mean volume �MPV� �y �7��% �p < �.��� and an increase in the distri�ution width �PDW�. This phenomenon occurs in the case of intense production of young PLT and their release in the �lood from the �one marrow� which actively compensates their destruction [�6] .
Influence of MTF, DCA and their combination on survival of rats with C6 glioma and blood indices of animals. It was found that due to the ��day long therapy with DCA� MTF and their com�ination� the positive antitumor effect on C6 glioma was recorded in the groups of rats receiving MTF alone or a com �ination of MTF and DCA. While DCA therapy did not affect the life span of rats with C6 glioma� the intro duction of MTF statistically significantly lengthened the life span of rats with tumors �y �9.�% �p < �.���� and the com�ined administration of the agents gave a significant antigliomic effect and prolongation of life of the animals �y ��% �p < �.����. It should �e noted that the high effectiveness of antitumor com�ined therapy with these agents was most likely due to syn ergistic effects of MTF and DCA on the development of C6 glioma �Fig. ��.
In the a�sence of antitumor activity of DCA against C6 glioma� the administration of this agent caused a positive effect on some indices of �oth red and white cell lineages of peripheral �lood in rats.
Analysis of hemogram data after DCA therapy indicated that this agent has the a�ility to correct the manifestations of anemia in rats with C6 glioma. That is� the levels of RBC� Hg� and HCT in the �lood of the experimental group of animals were within the normal limits �Ta�le ��� which indicated the normal functional a�ility of erythrocytes to carry oxygen. A low� how ever� significant �p < �.��� increase in the MCV index �y �.7% in the �lood of tumor�earing animals after treatment with DCA may �e due not only to the glioma development �ut also to the direct effect of DCA� since intake of this agent may �e accompanied �y the defi ciency of vitamins of group B in the �ody� which mani fests itself in reducing the proportion of RBC against the �ackground of their increased volume.
There was also recorded a marked tendency to increase of the total level of leukocytes in rats after administration of DCA practically to the level of this in intact animals �Ta�le ��. The a�sence of statistically significant results is due to the large range of deviations characteristic of the studied parameters in the group of animals administered with DCA.
The study of PLT counts and PLT indices showed that DCA did not affect the development of throm�o cytopenia in rats with transplanted tumors. Despite the lack of significant changes in HCT� the level of PLT in the �lood of rats with C6 glioma after action of DCA was almost at the level of tumor control and was lower than that in intact controls �y ��.�% �p < �.���. As can �e seen from Ta�le �� the MPV level in the studied animals groups was higher than in intact control �y ��.3% �p < �.���� and PDW tended to increase� indicating a predominance of young PLT in the �lood of this group of rats at the �ackground of destruction of mature ones. In contrast to DCA� the introduction of MTF caused a complete normalization of �lood leucogram in the animals. As a result of �� daylong treatment with MTF� the level of WBC and� respectively� LY� MO and GR did not differ from those in intact animals and significantly �p < �.��� exceeded the corresponding tumor control parameters �y 93.�; ��.�; ���.� and ���.�% �Ta�le ��. The o�tained data confirm the a�ility of MTF to normal ize the immune system� as previously demonstrated in the study on the role of the immune system in the mechanisms of the therapeutic effect of MTF in pa tients with type II dia�etes mellitus [�7].
The most significant positive changes after MTF therapy were recorded in the indicators of the PLT �ranch of hematopoiesis. As can �e seen from Ta�le �� PLT count significantly increased �y �3�% �p < �.���� compared with tumor control� reaching the level of this index in the �lood of intact rats. At the same time� the MTF had a weak �ut positive effect on the erythrocytic �ranch of hematopoiesis: levels of RBC� Hg�� HCT� RDW and MCH did not differ from the corresponding indices of intact rats. An insignificant increase in the volume of erythrocytes in the �lood of investigated animals may �e due to the fact that MTF has the a�ility to accumulate in RBC� there�y playing the role of depot of MTF in the �ody [�����] .
It was shown that due to the com�ined therapy with inhi�itors of energy meta�olism� MTF and DCA� the level of WBC in the �lood of rats with glioma somewhat increased ��y 36.�%� p < �.��� in comparison with the control group �ut still was significantly lower than the corresponding index in healthy animals� mainly due to the significant �p < �.��� decrease of the LY level �y 39.�% �Ta�le ��.
The analysis of the hemogram �Ta�le �� showed that the com�ined therapy with MTF and DCA pro vided the correction of anemia and throm�ocytopenia more likely due to the direct effect of MTF on these �lood indices. The latter is evidenced �y the a�sence of significant differences �etween hemograms of rats treated with MTF or com�ined therapy.
As it is known� under physiological conditions� the PLT count in the �lood is in equili�rium� which is supported �y a constant ratio of regeneration and elimination. At the same time� the throm�ocrit value� reflecting the percentage of PLT volume in the total volume of �lood� is directly related to the num�er of PLT� whereas the MPV index is inversely proportional to these values [����3] . MPV is considered a good marker for differential diagnosis of throm�ocytopenia. An increase in this index is o�served in a hyperdestruc tive form [����6] and in the case of tumor disease it is supposed to �e associated with a negative prog nosis. It is worth noting that today the MPV/PLT ratio is considered as one of the markers of the effective ness of antitumor therapy [�7� ��]. At the same time� the decrease of this index to the level typical of healthy animals indicated the effectiveness of therapy. The analysis of the o�tained results allowed to calculate the average value and find the range of values of the MPV/ PLT ratio for healthy animals� animals with C6 glioma and tumor�earing rats treated with MTF� DCA and their com�ination.
It was shown� that the growth of C6 glioma is charac terized �y the statistically signfcant increase of MPV/ PLTs ratio �y 3��% compared with the corresponding indices of intact control �Ta�le 3�. The use of MTF and MTF in com�ination with DCA significantly reduced this index �y 7�.�% �p < �.��� compared with tumor control� which correlated with the positive result of antitumor therapy. Despite the tendency to decrease of the MPV/PLT ratio in the animal group after DCA therapy� no significant changes were recorded for this index compared to tumor control� which correlated with the a�sence of antitumor efficacy of DCA therapy of C6 glioma. It is known that �rain tumors are characterized �y intense glycolysis and are highly dependent on the circulating glucose [�9]. Therefore� the influence of DCA and MTF com�inaton on the level of lactate and glucose may contri�ute to their expressed antiglioma effect. The main antitumor effect of DCA is �elieved to �e realized due to its a�ility to activate oxidative phosphorylation in tumor cells and depolarize the mitochondrial mem�rane� which causes increased production of active oxygen species� and� as a con sequence� induction of apoptosis [3�]. On the other hand� MTF is a hypoglycemic agent widely used in the treatment of type II dia�etes mellitus in order to reduce �lood glucose levels. In addition� it is an inhi�itor of the Ist complex of the electron transport chain of mito chondria� and at the initial respiratory stage� it is a�le to "shut off" the Kre�s cycle.
As can �e seen from Fig. �� the growth of C6 glioma was accompanied �y a statistically significant de crease in glucose level in peripheral �lood of animals �y ��% �p < �.���� which was most likely due to the high need of glycolytic tumor in the level of this energy su�strate. Interestingly� after administration of either DCA� or MTF� glucose levels in rat �lood increased almost to the level of intact animals.
In the case of DCA� this may �e due to the inten sification of oxidative phosphorylation and inhi�ition of glycolysis in the cells of the �ody �y redirecting py Experimental Oncology ��� �������� ���� ��eptem�er� ��� �������� ���� ��eptem�er� ��eptem�er� ��9
ruvate to the Kre�s cycle. In favor of this evidenced the decrease in the level of lactate in the peripheral �lood of rats after the introduction of DCA. In the case of MTF� an increase in glucose levels in rat �lood can occur due to effective antiglioma activity� and as a conse quence of reducing the need of tumor in glucose. The most pronounced changes in �oth glucose and lactate levels were o�served in rats after com�ined therapy with DCA and MTF. Decrease of glucose level �y ��% �p < �.��� in comparison with this index of tumor con trol can �e directly related to the high antitumor effect of com�ined therapy. However� a significant decrease in the level of lactate �y ��.�% �p < �.��� indicated the a�ility of this com�ination of agents to significantly reduce the intensity of glycolysis� a factor that can make a signifi cant contri�ution to the antitumor activity of com�ination therapy. The question -in which cells �normal or tumor ones� DCA and MTF are capa�le to significantly inhi�it glycolysis� remains open and requires additional research.
CONCLUSION
Thus� this work demonstrated the a�ility of MTF either used alone or in com�ination with DCA to influ ence the development of C6 glioma which is mani fested in an increase in the lifespan of rats. The most pronounced antitumor activity was recorded against the �ackground of the com�ined use of these inhi�itors of energy meta�olism� which was shown to lengthen the life span of rats with C6 glioma �y ��% �p < �.����. In this case� the expressed antiglioma effect of MTF in com�ination with DCA may �e related to the a�ility of these agents to reduce the levels of lactate and glu cose in the �lood of tumor�earing rats. It is proved that MTF� used as monotherapy or in com�ination with DCA� provided the correction of anemia and throm�ocytope nia developing at the �ackground of C6 glioma growth. 
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